Skip to content

Optimizing and Innovating Blended Interventions and Aftercare for Alcohol Addiction (OptiBlend): A Randomized Controlled Trial

Optimizing and Innovating Blended Interventions and Aftercare for Alcohol Addiction (OptiBlend): A Randomized Controlled Trial - OptiBlend: Optimizing and innovating blended treatment for addiction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57089
Enrollment
298
Registered
2024-10-17
Start date
2024-12-09
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alcohol use disorder, with or without other substance use disorders alcohol addiction Alcohol use disorder

Interventions

Treatment as usual (TAU, comparator intervention): TAU is a manual-based cognitive behavioural therapy and motivational interviewing (CBT/MI) intervention, consisting of up to 14 individual F2F sess

Sponsors

Arkin (Amsterdam)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. AUD as primary diagnosis 2. Age 18+ 3. At least moderately proficient in Dutch 4. In possession of a smartphone and a tablet or computer at home 5. Voluntarily enrolled for A/SUD treatment at one of four trial sites 6. A current regular indication for blended care by an addiction treatment professional at intake

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Acute psychosis 2. Dementia 3. Indication for inpatient A/SUD treatment 4. Indication for involuntary or forensic care

Design outcomes

Primary

MeasureTime frame
The primary outcome in this study is the total alcohol consumed, based on the number of standard drinks (10 grams of ethanol) in the last 7 days.

Secondary

MeasureTime frame
The secondary outcomes of this study are (1) the odds of decreasing one's WHO risk drinking level by at least 1 level, and (2) treatment response. Treatment response indicates whether treatment is deemed successful or not. The treatment is deemed successful if both conditions are met (a) no more than 8 alcohol drinking days in the past 30 days prior to measurement and (b) no heavy drinking days (>3 standard drinks/day [females], >4 standard drinks/day [males]) in the past 30 days prior to measurement.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)